Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China
· Delayed Price · Currency is CNY 14.52
-0.11 (-0.75%)
Mar 9, 2026, 3:04 PM CST
SHE:002755 Revenue
Beijing Aosaikang Pharmaceutical had revenue of 426.48M CNY in the quarter ending September 30, 2025, a decrease of -7.67%. This brings the company's revenue in the last twelve months to 1.83B, up 6.96% year-over-year. In the year 2024, Beijing Aosaikang Pharmaceutical had annual revenue of 1.78B with 23.15% growth.
Revenue (ttm)
1.83B
Revenue Growth
+6.96%
P/S Ratio
7.38
Revenue / Employee
1.85M
Employees
988
Market Cap
13.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.78B | 334.18M | 23.15% |
| Dec 31, 2023 | 1.44B | -429.11M | -22.92% |
| Jan 1, 2023 | 1.87B | -1.23B | -39.72% |
| Jan 1, 2022 | 3.11B | -676.02M | -17.87% |
| Dec 31, 2020 | 3.78B | -735.94M | -16.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Chipscreen Biosciences | 909.54M |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |
| Shanghai Haoyuan Chemexpress | 2.87B |
| ApicHope Pharmaceutical Group | 1.02B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Guobang Pharma | 5.94B |
| Guangdong Taienkang Pharmaceutical | 674.49M |